Arkolith/Insider Trading/ELOX/Form 4

Pontifax Management 4 G.P. (2015) Ltd.

10% OwnerEloxx Pharmaceuticals, Inc. (ELOX) · full profile →Form 4 · filed May 17, 2021
Net Buying
Open-Market Buys
$8.0M
Open-Market Sells
$0
Net Open-Market Flow
$8.0M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2021Buy(P)593K$1.35$800K617K
May 13, 2021Buy(P)1.4M$1.35$1.9M2.0M
May 13, 2021Buy(P)2.6M$1.35$3.6M3.7M
May 13, 2021Buy(P)1.3M$1.35$1.7M1.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-067336) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Eloxx Pharmaceuticals, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp